Back to search

Article

Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation

2022-06-17

Abstract excerpt

<h4>SUMMARY</h4> Multiple system atrophy (MSA) is a neurodegenerative disease showing accumulation of misfolded α-synuclein and myelin disruption. However, the mechanism how α-synuclein (α-syn) accumulate in MSA brain remains unclear. Here, we identify the protein epsin-2 as a novel target for MSA therapy via controlling α-synuclein accumulation. In MSA mouse model, PLP-hαSyn transgenic mice and FABP7/α-syn heter...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
da4532f7-b1c5-5461-9c4a-9f7862857504
DOI
10.1101/2022.06.16.496509
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagationDOI 10.1101/2022.06.16.496509
Select a neighboring publication to make it the new centre.